YL-13027 in Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ignacio Ga Laguna,, MD, Ph.D
Huntsman Cancer Institute Salt Lake City, UT 84112
Principal Investigator - Jordi Ah Rodon, Ph D
MD Anderson Cancer Center Houston TX 77030
Principal Investigator - Martin E Gutierrez, MD
Hackensack University Medical Center Hackensack, NJ 07601
Principal Investigator - Trisha Wi Draper, Ph D
University of Cincinnati Cincinnati, OH 45267-0562
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 May 2022
- Primary completion
- 30 Dec 2022
- Completion
- 1 Dec 2023
- Last update posted
- 20 May 2022
- Registered enrollment
- 54
- Registry id
- NCT05228600
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.